Previous treatment with ebselen and vitamin E alters adenine nucleotide hydrolysis in platelets from adult rats experimentally demyelinated with ethidium bromide

Life Sciences

Volumn 81, Issue 3, 2007, Pages 241-248

  Mazzanti, Cinthia M ^a   Spanevello, Roselia M ^a   Morsch, André ^b   Zanin, Rafael ^b   Battisti, Vanessa ^b   Ahmed, Mushtaq ^b   Gonçalves, Jamile F ^b   Mazzanti, Alexandre ^b   Graça, Dominguita L ^b   Morsch, Vera M ^b   Schetinger, Maria Rosa C ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

5 nucleotidase; Demyelination; Ebselen; NTPDase; Platelets; Vitamin E

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOTIDE; ALPHA TOCOPHEROL; EBSELEN; ETHIDIUM BROMIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVITY; ENZYME ASSAY; HYDROLYSIS; MALE; NONHUMAN; RAT; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

5'-NUCLEOTIDASE; ADENINE NUCLEOTIDES; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; AZOLES; BLOOD PLATELETS; DEMYELINATING DISEASES; ETHIDIUM; HYDROLYSIS; MALE; ORGANOSELENIUM COMPOUNDS; PONS; RATS; RATS, WISTAR; VITAMIN E;

ANIMALIA; RATTUS;

EID: 34250814456     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.05.008     Document Type: Article

References (62)

1. Afonsi G., Russo I., Massuco P., Mattielo L., Cavalot F., Balbo A., and Trovati M. Adenosine increases human platelet levels of cGMP through role in this antiaggregating effect. Thrombosis Research 105 1 (2002) 71-78
2. Araújo M.C., Rocha J.B.T., Morsch A., Zanin R., Bauchspiess R., Morsch V.M., and Schetinger M.R.C. Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients. Biochimica et Biophysica Acta 1740 3 (2005) 421-426
3. Atkinson B., Dwyer K., Enjyoji K., and Robson S.C. Ecto-nucleotidases of the CD39/ NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells, Molecules & Diseases 36 2 (2006) 217-222
4. Azzi A., Ricciarelli R., and Zing J.M. Non-antioxidant molecular functions of α-tocopherol (vitamin E). FEBS Letters 519 1-3 (2002) 8-10
5. Birk A.V., Broekman J., Gladek E.M., Robertson H.D., Drosopoulos J.H.F., Marcus A.J., and Szeto H. Role of a novel soluble nucleotide phosphohydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology. Journal of Laboratory and Clinical Medicine 139 2 (2002) 116-124
6. Birk A.V., Broekman J., Gladek E.M., Robertson H.D., Drosopoulos J.H.F., Marcus A.J., and Szeto H. Role of extracellular ATP metabolism in regulation of platelet reactivity. Journal of Laboratory and Clinical Medicine 140 3 (2002) 166-175
7. Bohmer A.E., Furstenau C.R., Torres I.L., Crema L., Battastini A.M.O., Dalmaz C., Ferreira M.B.C., and Sarkis J.J.F. The effect of stress upon hydrolysis adenine nucleotides in blood serum of rats. Pharmacology, Biochemistry and Behavior 75 2 (2003) 467-471
8. +-ATPase activity in rats. Toxicology 215 3 (2005) 191-197
9. Boscoboinik D., Szewezyk A., Hensey C., and Azzi A. Inhibition of cell proliferation by α-tocopherol: role of protein kinase C. Journal of Biological Chemistry 226 1 (1991) 6188-6194
10. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
11. Buffon A., Ribeiro V.B., Furstenau C.R., Battastini A.M.O., and Sarkis J.J.F. Acetylsalicylic acid inhibits ATP diphosphohydrolase activity by platelets from adult rats. Clinica Chimica Acta 349 1-2 (2004) 53-60
12. Cananzi A.R., Ferro-Milone F., Grigolleto F., Toldo M., Meneghini F., Bortolon F., and D'Andrea G. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis. Acta Neurologica Scandinavica 76 2 (1987) 79-85
13. Cattabeni F., Colciaghi F., and Di Luca M. Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease. Progress in Neuro-Psychopharmacology 28 5 (2004) 763-770
14. 2+-ATPase activity. Analytical Biochemistry 157 2 (1986) 375-378
15. Chiang T.M., Whitaker J.N., Kang A.H., and Beachey E.H. The effect of myelin basic protein on the endogenous phosphorylation of platelets. Thrombosis Research 25 (1982) 487-499
16. Engman L., and Hallberg A. Expedient synthesis of ebselen and related compounds. Journal of Organic Chemistry 54 6 (1989) 2964-2966
17. Ferrarese C., Begni B., Cavenari C., Zoia C., Piolti R., Frigo M., Appollonia I., and Frattola L. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Annals of Neurology 47 (2000) 641-643
18. Freedman J.E., Farhat J.H., Loscalzo J., and Keaney J.F. α-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94 10 (1996) 2434-2440
19. Freedman J.E., Li L., Sauter R., and Keaney J.F. α-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. Journal of Publication of the Federation of American Societies for Experimental Biology 14 15 (2000) 2377-2379
20. Furstenau C.R., Spier A.P., Rucker B., Berti S.L., Battastini A.M.O., and Sarkis J.J.F. The effects of ebselen on adenine nucleotide hydrolysis by platelets from adult rats. Chemico-Biological Interactions 148 1-2 (2004) 93-99
21. Gibbs P., Green M., and Basser R. Thrombocytopenia: new approaches to resolve a major problem in chemotherapy. Cancer 8 (1995) 255-259
22. Jialal I., Traber M., and Devaraj S. Is there a vitamin E paradox?. Current Opinion in Lipidology 12 1 (2001) 49-53
23. Johonson S. The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D and E and essential fatty acids in multiple sclerosis. Medical Hypotheses 55 3 (2000) 239-241
24. Keating F., Whitaker D., Kabbani S., Ricci M., Sobel B., and Schneider D. Relation of augment platelet reactivity to the magnitude of distribution of atherosclerosis. American Journal of Cardiology 94 (2004) 725-728
25. Khan S.N., Belin J., Smith A.D., Sidey M., and Zilkha K.J. Response to platelet-activating factor of platelets from patients with multiple sclerosis. Acta Neurologica Scandinavica 71 3 (1985) 212-220
26. Kobzar G., Mardla V., and Samel N. Effects of α-tocopherol, l-arginine, and quercetin on aggregation of human platelets. Nutrition Research 25 1 (2005) 569-575
27. Levine J.M., and Reynolds R. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Experimental Neurology 160 2 (1999) 333-347
28. Lunkes G.I., Lunkes D., Stefanello F., Morsch A., Morsch V., Mazzanti C.M., and Schetinger M.R.C. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thrombosis Research 109 4 (2003) 189-194
29. Lunkes G., Lunkes D., Morsch V., Mazzanti C., Morsch A., Miron V., and Schetinger M.R.C. NTPDase and 5′-nucleotidase in rats alloxan-induced diabetes. Diabetes Research and Clinical Practice 65 1 (2004) 1-6
30. Mabile L., Bruckdorfer K.R., and Evans C.R. Moderate supplementation with natural α-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atherosclerosis 147 1 (1999) 177-185
31. Meotti F.C., Borges V.C., Zeni G., Rocha J.B.T., and Nogueira C.W. Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and ebselen for rats and mice. Toxicology Letters 143 1 (2003) 9-16
32. Millar J.H.D., Merret J.D., and Dalby A. Platelet stickiness in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 29 3 (1966) 187-189
33. Morin D., Zini R., Ligeret H., Neckameyer W., Labidalle S., and Tillement J.P. Dual effect of ebselen on mithocondrial permeability transition. Biochemical Pharmacology 65 10 (2003) 1643-1651
34. Neu I.S., Prosiegel M., and Pfaffenrath V. Platelet aggregation and multiple sclerosis. Acta Neurologica Scandinavica 66 4 (1982) 497-504
35. Nogueira C.W., Meotti F.C., Curte E., Pilissão C., Zeni G., and Rocha J.B.T. Investigations into the potential neurotoxicity induced by disselenides in mice and rats. Toxicology 183 1-3 (2003) 29-37
36. Odagaki Y., and Koyama T. Epinephrine and thrombin-stimulated high affinity GTPase activity in platelets membranes from patients with psychiatric disorders. Psychiatry Research 112 2 (2002) 111-119
37. Panasiuk A., Prokopowicz D., Zak J., Panasiuk B., and Wysocka J. Inhibition of activated blood platelets by interferon Alfa 2b in chronic hepatitis C. Hepato-Gastroenterology 51 59 (2004) 1417-1421
38. Pilla C., Emanuelli T., Frassetto S.S., Battastini A.M.O., Dias R.D., and Sarkis J.J.F. ATP diphosphohydrolase activity (apyrase, E.C. 3.6.1.5) in human blood platelets. Platelets 7 (1996) 225-230
39. Quinn P.J. Antioxidants and prophylactics. Is the distribution of α-tocopherol in membranes consistent with its putative function?. Biochemistry 69 1 (2004) 74-84
40. Rainesalo S., Keranen T., Peltola J., and Saransaari P. Glutamate uptake in blood platelets from epileptic patients. Neurochemistry International 43 4-5 (2003) 389-392
41. Remijin J.A., Wu Y., Jeninga E.H., Ljsseldijk J.W., Willigen G., Groot P., Sixma J., Nurden A., and Nurden P. Role of ADP receptor P2y12 in platelet adhesion and thrombus formation in flowing blood. Arteriosclerosis, Thrombosis, and Vascular Biology 22 4 (2002) 686-691
42. Reynolds R., Cenci di Bello I., Meeson A., and Piddlesden S. Comparison of a chemically mediated and an immunologically mediated demyelinating lesion model. Methods: A Companion to Methods in Enzymology 10 3 (1996) 440-452
43. Rimbach G., Minihane A.M., Majewicz J., Fischer A., Pallauf J., Virgli F., and Weinberg P.D. Regulation of cell signalling by vitamin E. Proceedings of the Nutrition Society 61 4 (2002) 415-425
44. Rozalski M., Nocun M., and Watala C. Adenosine diphosphate receptors on blood platelets - potential new targets for antiplatelet therapy. Acta Biochimica Polonica 52 2 (2005) 411-415
45. Schetinger M.R.C., Falchembach F., Michelot F., Mezzomo M., and Rocha J.B.T. Heparin modulates adenine nucleotide hydrolysis by synaptosomes from cerebral cortex. Neurochemistry International 33 3 (1998) 243-249
46. Schoene N.W. Effects of α-tocopherol, L-arginina, and quercetin on aggregation of human platelets. Nutrition 17 10 (2001) 793-796
47. Silva A.C., Morsch A.L.B., Zanin R.F., Côrrea M.C., Arantes L.C., Araújo M.C., Morsch V.M., and Schetinger M.R.C. Enzymes that hydrolyze adenine nucleotides in chronic renal failure: relationship between hemostatic defects and renal failure severity. Biochimica et Biophysica Acta 1741 3 (2005) 282-288
48. Smith P.M., and Franklin R.J.M. The effect of immunosuppressive protocols on spontaneous CNS remyelination following toxin-induced demyelination. Journal of Neuroimmunology 119 2 (2001) 261-268
49. Soslau G., and Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochimica et Biophysica Acta 1355 2 (1997) 131-140
50. Spanevello R.M., Mazzanti C.M., Kaizer R., Zanin R., Cargnelluti L., Hannel L., Correa M., Mazzanti A., Festugatto R., Graça D., Schetinger M.R.C., and Morsch V. NTPDase and 5′-nucleotidade activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon β. Neurochemical Research 31 4 (2006) 455-462
51. Spanevello R.M., Mazzanti C.M., Maldonado P., Zanin R., Morsch A., Hannel L., Mazzanti A., Festugatto R., Graça D., Schamtz R., Loro V.L., Schetinger M.R.C., and Morsch V. Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon β. Life Science 80 12 (2006) 1109-1114
52. Stangel M., and Hartung H.P. Remyelinating strategies for treatment of multiple sclerosis. Progress in Neurobiology 68 5 (2002) 361-376
53. Steiner M. Vitamin E: more than an antioxidant. Clinical Cardiology 16 4 (1993) 16-48
54. Steiner M., and Anastasi J. Vitamin E an inhibitor of the platelet release reaction. Journal of Clinical Investigation 57 3 (1976) 732-737
55. Su J.J., Osoegawa M., Matsuoka T., Minohara M., Tanaka M., Ishizu T., Mihara F., Taniwaki T., and Kira J. Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings. Journal of Neurological Science 243 1-2 (2006) 21-30
56. Szuwart T., Brzoska T., Luger T.A., Filler T., Peuker E., and Dierichs R. Vitamin E reduces platelets adhesion to human endothelial cells in vitro. American Journal of Hematology 65 1 (2000) 1-4
57. Tsiara S.N., Christou K., Panteli K., Anastasopoulos D., and Bourantas K.L. A patient with essential thrombocytocis and multiple sclerosis. European Journal of Internal Medicine 11 6 (2000) 345-347
58. Wadenvik H., Kutti J., Ridell B., Revez P., Jacobson S., Magnossun B., Westin J., and Vilen L. The effect of alpha interferon on bone marrow megakaryocyte and platelet production rate in essential thrombocythemia. Blood 77 10 (1991) 2103-2108
59. Wagner D.D., and Burger P. Platelets in inflammation and thrombosis. Arteriosclerosis, Thrombosis and Vascular Biology 23 (2003) 2131-2137
60. Whitin J.C., Gordon R.K., Corwin L.M., and Simons E.R. The effect of vitamin E deficiency on some platelet membrane properties. Journal of Lipid Research 23 2 (1982) 276-282
61. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Development Research 52 (2001) 44-56
62. Zing J.M., and Azzi A. Non-antioxidant activities of vitamin E. Current Medicinal Chemistry 11 9 (2004) 1113-1133